title: Introduction: examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline).
authors.affiliation: Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224.
authors.forename: S R
authors.initials: SR
authors.lastname: Goldberg
authors.forename: S
authors.initials: S
authors.lastname: Yasar
authors.forename: J
authors.initials: J
authors.lastname: Bergman
authors.forename: M B
authors.initials: MB
authors.lastname: Youdim
mesh_terms: D000818:Animals; D006801:Humans; D012642:Selegiline / Q000009:adverse effects* / Q000633:toxicity; D019966:Substance-Related Disorders / Q000209:etiology*
chemical_list: D012642:Selegiline